<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Res</journal-id><journal-id journal-id-type="iso-abbrev">Vet. Res</journal-id><journal-title-group><journal-title>Veterinary Research</journal-title></journal-title-group><issn pub-type="ppub">0928-4249</issn><issn pub-type="epub">1297-9716</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5667440</article-id><article-id pub-id-type="publisher-id">476</article-id><article-id pub-id-type="doi">10.1186/s13567-017-0476-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Variability in the response of canine and human dendritic cells stimulated with <italic>Brucella canis</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pujol</surname><given-names>Myriam</given-names></name><address><email>myriampujol@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Castillo</surname><given-names>Francisca</given-names></name><address><email>francisca.castillo.p@ug.uchile.cl</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Alvarez</surname><given-names>Carla</given-names></name><address><email>carla.alvarez.rivas@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Rojas</surname><given-names>Camila</given-names></name><address><email>camilafrl@live.cl</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Borie</surname><given-names>Consuelo</given-names></name><address><email>cborie@uchile.cl</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Ferreira</surname><given-names>Arturo</given-names></name><address><email>aferreir@med.uchile.cl</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Vernal</surname><given-names>Rolando</given-names></name><address><email>rvernal@uchile.cl</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution>Doctoral Program in Agronomy Forestry and Veterinary Sciences, Faculty of Veterinary Sciences, </institution><institution>Universidad de Chile, </institution></institution-wrap>Santiago, Chile </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution>Periodontal Biology Laboratory, Faculty of Dentistry, </institution><institution>Universidad de Chile, </institution></institution-wrap>Santiago, Chile </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution>Laboratory of Veterinary Bacteriology, Department of Animal Preventive Medicine, Faculty of Veterinary Sciences, </institution><institution>Universidad de Chile, </institution></institution-wrap>Santiago, Chile </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0385 4466</institution-id><institution-id institution-id-type="GRID">grid.443909.3</institution-id><institution>Program of Immunology, Institute of Biomedical Sciences ICBM, Faculty of Medicine, </institution><institution>Universidad de Chile, </institution></institution-wrap>Santiago, Chile </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.441837.d</institution-id><institution>Dentistry Unit, Faculty of Health Sciences, </institution><institution>Universidad Aut&#x000f3;noma de Chile, </institution></institution-wrap>Santiago, Chile </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>11</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>2</day><month>11</month><year>2017</year></pub-date><pub-date pub-type="ppub"><year>2017</year></pub-date><volume>48</volume><elocation-id>72</elocation-id><history><date date-type="received"><day>26</day><month>5</month><year>2017</year></date><date date-type="accepted"><day>16</day><month>10</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">
<italic>Brucella canis</italic> is a small intracellular Gram-negative bacterium whose primary host is the dog, but it also can cause mild human brucellosis. One of the main causes of an inefficient immune response against other species of <italic>Brucella</italic> is their interaction with dendritic cells (DCs), which affects antigen presentation and impairs the development of an effective Th1 immune response. This study analysed the cytokine pattern production, by RT-qPCR and ELISA, in human and canine DCs against whole <italic>B. canis</italic> or its purified LPS. Human and canine DCs produced different patterns of cytokines after stimulation with <italic>B. canis</italic>. In particular, while human DCs produced a Th1-pattern of cytokines (IL-1&#x003b2;, IL-12, and TNF-&#x003b1;), canine cells produced both Th1 and Th17-related cytokines (IL-6, IL-12, IL-17, and IFN-&#x003b3;). Thus, differences in susceptibility and pathogenicity between these two hosts could be explained, at least partly, by the distinct cytokine patterns observed in this study, where we propose that human DCs induce an effective Th1 immune response to control the infection, while canine DCs lead to a less effective immune response, with the activation of Th17-related response ineffective to control the <italic>B. canis</italic> infection.</p><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1186/s13567-017-0476-8) contains supplementary material, which is available to authorized users.</p></sec></abstract><funding-group><award-group><funding-source><institution>Comisi&#x000f3;n Nacional de Investigaci&#x000f3;n Cient&#x000ed;fica y Tecnol&#x000f3;gica (CONICYT)</institution></funding-source><award-id>FONDECYT 1140904</award-id><award-id>CONICYT 21130626</award-id><principal-award-recipient><name><surname>Pujol</surname><given-names>Myriam</given-names></name><name><surname>Vernal</surname><given-names>Rolando</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">
<italic>Brucella canis</italic>, a small Gram-negative facultative intracellular coccobacillus, belonging to the <italic>Brucella</italic> genus and <italic>Proteobacteria</italic> phylum, is responsible for canine brucellosis [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. It is a worldwide distributed zoonotic pathogen whose prevalence is unknown, because routine human brucellosis diagnosis does not include <italic>B. canis</italic> detection [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par3">Canine brucellosis is considered the main cause of reproductive failures in dogs [<xref ref-type="bibr" rid="CR4">4</xref>], provoking late abortions in females and epididymitis and/or prostatitis in male dogs, leading to infertility, and non-reproductive symptoms such as ophthalmitis, diskospondylitis, lymphadenopathy, and splenomegaly [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Both, infected dogs and healthy dogs harbouring <italic>B. canis</italic> have the potential to transmit the bacteria to humans, mainly by oronasal contact, occupational interaction with infected animals, or laboratory accidents [<xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR9">9</xref>]. When humans are infected, <italic>B. canis</italic> frequently induce mild or asymptomatic infections that may remain undiagnosed for protracted periods [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref>] and clinical signs include headache, recurrent fever, weakness, fatigue, chills, sweats, and weight loss [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par4">There is strong evidence indicating the relevance of dendritic cells (DCs) function in the pattern of inflammatory-immune response triggered against other <italic>Brucella</italic> species [<xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>]. Due to the differences in the clinical manifestation between dogs and human during <italic>B. canis</italic> infection, this study aims to assess whether their DCs, when exposed to <italic>B. canis,</italic> produce different patterns of immune response. We hypothesized that <italic>B. canis</italic> interacts differently with human and canine DCs leading to distinct pattern of cytokine expression, thus contributing to explain, at least partially, the different susceptibility and pathogenicity observed in dogs and humans.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title><italic>Brucella canis</italic> isolation and characterization</title><p id="Par5">The <italic>B. canis</italic> strain SCL was isolated from an urine sample of a male stray dog which had been recently admitted to a dog shelter in Santiago, Chile. The dog had clinical history of urinary symptoms, including inflammation, pain and haematuria, and was positive to a counterimmunoelectrophoresis serological test using <italic>B. ovis</italic> LPS antigen [<xref ref-type="bibr" rid="CR19">19</xref>]. Bacterial growth was performed in <italic>Brucella</italic> agar 5% sheep blood and morphological and biochemical characteristics were compatible with <italic>B. canis</italic>, including CO<sub>2</sub> requirement, oxidase, urease, catalase, citrate utilization, sugar fermentation, and H<sub>2</sub>S production [<xref ref-type="bibr" rid="CR20">20</xref>]. The <italic>B. canis</italic> strain SCL was fully sequenced (Next-Generation Illumina MiSeq Platform<sup>&#x000ae;</sup>; Illumina Inc., San Diego, CA, USA), at the Favet-Inbiogen Laboratory belonging to the Faculty of Veterinary Sciences, Universidad de Chile, under the GenBank accession number LGAQ00000000.1. Finally, the <italic>Brucella</italic> genus was confirmed by qPCR, using a Real Time PCR Detection Kit (Genesig<sup>&#x000ae;</sup>; Southampton, UK) in a StepOnePlus<sup>&#x000ae;</sup> qPCR equipment (Applied Biosystems, Singapore).</p></sec><sec id="Sec4"><title><italic>Brucella canis</italic> growth conditions and curves</title><p id="Par6">The <italic>B. canis</italic> strain SCL was cultured on 5% bovine serum tripticase soy agar or 5% horse blood agar (Oxoid Ltd, Hampshire, UK) and incubated at 37&#x000a0;&#x000b0;C under aerobic conditions. Bacterial growth curves were obtained in 5% bovine serum tripticase soy broth (Oxoid Ltd) incubated at 37&#x000a0;&#x000b0;C with constant orbital shaking. Briefly, bacterial samples were inoculated in 4&#x000a0;mL of broth until reaching an optical density (OD) of 0.05, as measured by spectrophotometry at a wavelength of 560&#x000a0;nm (Halo RB-10; Dynamica Scientific Ltd., United Kingdom). The spectrophotometry readings were taken every 1&#x000a0;h and the experiment was stopped when <italic>B. canis</italic> reached the stationary growth phase (30&#x000a0;h). With each OD measurement, a sample was taken, log<sub>10</sub> serially diluted in PBS, and 100&#x000a0;&#x000b5;L of each dilution were cultured on tripticase soy agar and incubated at 37&#x000a0;&#x000b0;C. Finally, the number of colony-forming units/mL (CFU/mL) counted was plotted against the corresponding OD reading. For DC stimulation with whole <italic>B. canis</italic>, bacteria were taken at the exponential growth phase in order to obtain a reliable number of live bacteria having their whole antigenic potentiality.</p></sec><sec id="Sec5"><title><italic>Brucella canis</italic> LPS purification</title><p id="Par7">For DC stimulation with purified lipopolysaccharide (LPS), <italic>B. canis</italic> LPS was obtained using a modified version of the TRIzol reagent protocol as described previously [<xref ref-type="bibr" rid="CR21">21</xref>]. Briefly, <italic>B. canis</italic> was cultured in 200&#x000a0;mL of tripticase soy broth until it reached the stationary growth phase and was immediately pelleted by centrifugation at 6000<italic>&#x000a0;g</italic> for 10&#x000a0;min. The pellet was washed with distilled water and then incubated in 3&#x000a0;mL of TRIzol reagent (TRIzol<sup>&#x000ae;</sup> Plus; Invitrogen Corp., Barcelona, Spain) and 600&#x000a0;&#x000b5;L chloroform (Fluka, Sigma-Aldrich Chemie GmbH, Buchs, Switzerland) at room temperature for 30&#x000a0;min. After centrifugation, the aqueous phase was treated with proteinase K, RNase and DNase (Sigma-Aldrich, St. Louis, MO, USA) and lyophilized overnight. The obtained LPS was then resuspended in 1&#x000a0;mL of 95% ethanol with 0.375&#x000a0;M MgCl<sub>2</sub>, washed three times with cold 100% ethanol, and purified with 1% Folch reagent containing 2:1 chloroform and methanol. Finally, the LPS was dried overnight in a fume cabinet, quantified using the malondialdehyde thiobarbituric acid reaction, resuspended in milli-Q water as stock solution, and stored at &#x02212;20&#x000a0;&#x000b0;C [<xref ref-type="bibr" rid="CR21">21</xref>]. LPS was visualized by sodium dodecyl sulphate-14% polyacrylamide gel electrophoresis (SDS-PAGE) and periodic acid-silver staining as described previously [<xref ref-type="bibr" rid="CR22">22</xref>]. Coomassie blue stained gels were used to determine absence of protein contamination. <italic>B. canis</italic> manipulation was carried out inside a biosafety cabinet and approved by the Biosafety Committee from North Campus, Universidad de Chile.</p></sec><sec id="Sec6"><title>Peripheral blood samples</title><p id="Par8">Peripheral blood samples were obtained from 10 healthy human and 10 healthy dogs. For human samples, buffy coats were obtained from healthy female and male consenting adults from the Clinical Hospital Jos&#x000e9; Joaqu&#x000ed;n Aguirre, Universidad de Chile. An extensive anamnesis was performed and criteria for individual selection were as follows: absence of fever or manifest infections during the last month, absence of concomitant systemic disease or pregnancy, and no medical history of brucellosis. Further exclusion criteria were positive tests for human immunodeficiency virus, hepatitis B or C viruses, symptomatic allergies, abnormal blood cell counts, increased liver enzymes, or medication of any kind except vitamins and oral contraceptives. The study was approved by the Ethics Committee on Human Research, Universidad de Chile. Dog blood samples were obtained by venipuncture into heparin tubes (Vacutainer<sup>&#x000ae;</sup>; Becton&#x02013;Dickinson and Company, New Jersey, NJ, USA) after clinical, hematological and biochemical evaluation, together with counterimmunoelectrophoresis serological analysis, using <italic>B. ovis</italic> LPS antigen [<xref ref-type="bibr" rid="CR19">19</xref>], in order to discard the presence of brucellosis. Dog donors were female and male belonging to private owners, aged 1&#x02013;7&#x000a0;years, regularly dewormed and vaccinated against distemper, leptospirosis, parvovirus, parainfluenza, canine adenovirus type 2, canine hepatitis, and rabies. Dog owners provided written informed consent approved by the Committee for Animal Care and Use, Universidad de Chile, and all procedures were conducted according to Institutional Ethical Guidelines.</p></sec><sec id="Sec7"><title>Dendritic cell generation</title><p id="Par9">Human and canine DCs were generated using a three-step protocol as described previously [<xref ref-type="bibr" rid="CR23">23</xref>]. First, peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifugation using standard procedures (Ficoll-Paque Plus<sup>&#x000ae;</sup>; GE Healthcare, Uppsala, Sweden). Second, monocytes were purified from PBMCs by magnetic cell sorting using an anti-CD14 monoclonal antibody conjugated to magnetic beads (MACS<sup>&#x000ae;</sup>; Miltenyi Biotec, Bergisch Gladbach, Germany). Third, DCs were generated by culturing CD14<sup>+</sup> monocytes at 1&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> cells/mL for 6&#x000a0;days in RPMI-1640 (Life Technologies, Gaithersburg, MD, USA), supplemented with 10% foetal bovine serum, 100 U/mL penicillin, 100&#x000a0;&#x000b5;g/mL streptomycin, 2&#x000a0;mM&#x000a0;<sc>l</sc>-glutamine (Gibco Invitrogen Corp., Grand Island, NY, USA), 100&#x000a0;U/mL polymixin B (Sigma-Aldrich, St. Louis, MO, USA), and specific recombinant human (rh) or canine (rc) differentiation factors. In particular, canine monocyte cultures were supplemented with 40&#x000a0;ng/mL rhGM-CSF and 30&#x000a0;ng/mL rcIL-4 (R&#x00026;D Systems Inc., Minneapolis, MN, USA), while human monocyte cultures were supplemented with 20&#x000a0;ng/mL rhGM-CSF and rhIL-4 (R&#x00026;D Systems Inc.) every 2&#x000a0;days.</p></sec><sec id="Sec8"><title>Dendritic cell stimulation</title><p id="Par10">Differentiated DCs were then primed with live whole <italic>B. canis</italic> (MOIs&#x000a0;=&#x000a0;2&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;1</sup> to 2&#x000a0;&#x000d7;&#x000a0;10<sup>2</sup>) or <italic>B. canis</italic> purified LPS (10, 100&#x000a0;ng/mL or 1&#x000a0;&#x000b5;g/mL) for 24&#x000a0;h. Dendritic cells stimulated with 1&#x000a0;&#x000b5;g/mL LPS of <italic>Escherichia coli</italic> strain 0128:B12 (Sigma-Aldrich, St. Louis, MO, USA) and non-stimulated DCs were used as controls. For each subject, the experiments were performed separately. In each experimental step, cell counting was performed in a Neubauer<sup>&#x000ae;</sup> chamber using a phase contrast microscopy (AxioVert 100; Carl Zeiss Co., G&#x000f6;ttingen, Germany) and cell viability was calculated by Trypan blue dye exclusion.</p></sec><sec id="Sec9"><title>Phenotypic analysis of dendritic cell generation and activation by flow cytometry</title><p id="Par11">The canine and human monocyte differentiation towards DCs and their activation in the presence of <italic>B. canis</italic> were analyzed by flow cytometry as described previously [<xref ref-type="bibr" rid="CR23">23</xref>]. Differentiated DCs were stained with anti-CD1a, CD11c, and CD14 monoclonal antibodies (BD Biosciences Pharmingen, San Jos&#x000e9;, CA, USA) for 30&#x000a0;min at 4&#x000a0;&#x000b0;C in the dark and then analyzed using a flow cytometer (BD LSR Fortessa&#x02122;; Becton&#x02013;Dickinson, Pleasanton, CA, USA). In order to compare the activation and maturation levels of human DCs upon stimulation with <italic>B. canis</italic>, the expression levels of CD83 (specific marker of DC maturation) and CD86 (costimulatory signal expressed by DCs and necessary for T-lymphocyte activation during antigen presentation) were determined. In turn, the activation and maturation levels of canine DCs were determined by analysis of the expression of CD86 and DLAII (dog leucocyte antigen class II). Data from 6 independent experiments are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD, percentage of CD-positive cells and mean fluorescence intensity (MFI) for each surface marker.</p></sec><sec id="Sec10"><title>Morphologic cell analysis of stimulated dendritic cells by scanning electron microscopy</title><p id="Par12">The morphological changes observed in <italic>B. canis</italic>-stimulated human or canine DCs were analyzed by scanning electron microscopy. Briefly, DCs were fixed with 2% glutaraldehyde for 2&#x000a0;h, washed three-times with PBS, dehydrated through immersion in graded ethanol (50, 70, 95 and 100%), and dried at CO<sub>2</sub> critical point. Cells were then mounted on aluminium stubs, sputter-coated with gold layer to a thickness of 200&#x000a0;nm (Denton Vacuum Desk V; Moorestown, NJ, USA), and examined in a scanning electron microscope (Jeol JSMIT300LV; Jeol Ltd, Tokyo, Japan) at an accelerating voltage of 20&#x000a0;kV.</p></sec><sec id="Sec11"><title>Expression of cytokines by RT-qPCR</title><p id="Par13">After whole bacteria or LPS stimulation for 24&#x000a0;h, total cytoplasmic RNA was isolated from DCs using 400&#x000a0;&#x000b5;L of ice-cold lysis buffer containing 0.5% Igepal<sup>&#x000ae;</sup> CA-630 (Sigma-Aldrich, Saint Louis, MO, USA), 50&#x000a0;mM Tris&#x02013;HCl pH8, 100&#x000a0;mM NaCl, 5&#x000a0;mM MgCl<sub>2</sub>, and 10&#x000a0;mM VRC-40 (Gibco Invitrogen, Carlsbad, CA, USA) as described previously [<xref ref-type="bibr" rid="CR23">23</xref>]. Isolated RNA was quantified using a spectrophotometer (Synergy HT; Bio-Tek Instrument Inc., Winooski, VT, USA) and the first-strand cDNA strand was synthesized using 5&#x000a0;&#x000b5;g of total RNA and a reverse transcription kit following the manufacturer&#x02019;s protocol (Maxima First Strand cDNA Synthesis kit for RT-qPCR<sup>&#x000ae;</sup>; Thermo Scientific, Waltham, MA, USA). The mRNA expression for the cytokines IL-1&#x003b2;, IL-4, IL-5, IL-6, IL-10, IL-12p35, IL-13, IL-17, IL-23, IFN-&#x003b3;, TNF-&#x003b1;, and TGF-&#x003b2;1 were analyzed by RT-qPCR. Briefly, 50&#x000a0;ng of cDNA were amplified using the appropriate canine (Additional file <xref rid="MOESM1" ref-type="media">1</xref>) or human primers (Additional file <xref rid="MOESM2" ref-type="media">2</xref>) and the KAPA&#x02122; SYBR<sup>&#x000ae;</sup> Fast qPCR reagent (KAPA Biosystems, Woburn, MA, USA) in a StepOnePlus<sup>&#x000ae;</sup> qPCR equipment (Applied Biosystems) as follows: 95&#x000a0;&#x000b0;C for 3&#x000a0;min, followed by 40 cycles of 95&#x000a0;&#x000b0;C for 3&#x000a0;s and 60&#x000a0;&#x000b0;C for 30&#x000a0;s, and finally a melting curve of 95&#x000a0;&#x000b0;C for 15&#x000a0;s, 60&#x000a0;&#x000b0;C for 1&#x000a0;min and 95&#x000a0;&#x000b0;C for 15&#x000a0;s, for detection of non-specific product formation and false-positive amplification. Calibration curves were performed and a primer matrix was carried out to optimize the concentration of each primer, also in order to confirm the gene specificity for a single amplification product, a Blast search of the selected primers was performed in the Gene Bank sequence database. In human DCs, 18S ribosomal RNA (18S rRNA) expression levels were used as endogenous control. Due to insufficient background regarding the adequate choice of reference gene for cytokine expression in canine DCs, 3 frequently recommended reference genes were analyzed: 18S rRNA, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and TATA box binding protein (TBP) [<xref ref-type="bibr" rid="CR24">24</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>]. The expression level stability for these reference genes was analyzed using the NormFinder algorithm [<xref ref-type="bibr" rid="CR27">27</xref>]. Data from 10 independent experiments are shown as mean&#x000a0;&#x000b1;&#x000a0;SD. Each experiment was performed in duplicate.</p></sec><sec id="Sec12"><title>Secretion of cytokines by ELISA</title><p id="Par14">In addition, DC culture supernatants were collected and ELISA analysis was carried out to determine the secretion of human IL-12p70 and TNF-&#x003b1; (Quantikine<sup>&#x000ae;</sup>; R&#x00026;D Systems Inc.) and canine IL-17 and IFN-&#x003b3; (Nori Canine<sup>&#x000ae;</sup>; Genorise Scientific Inc., Philadelphia, PA, USA). Plates were quantified in an automatic microplate spectrophotometer (Synergy HT; Bio-Tek Instrument Inc.) according the manufacturer&#x02019;s instructions. Data from 7 independent experiments are shown as mean&#x000a0;&#x000b1;&#x000a0;SD.</p></sec><sec id="Sec13"><title>Statistical analysis</title><p id="Par15">The flow cytometry data were analyzed using the FlowJo software v9.6.4 (TreeStar, Ashland, ORE, USA), represented as histograms, and expressed as the percentage of positive cells over the total. The RT-qPCR data were analyzed using the StepOne Software v2.2.2 (Applied Biosystems) and the relative quantification was obtained by normalizing the cytokine expression to endogenous control expression using the 2<sup>&#x02212;&#x00394;&#x00394;Ct</sup> method. The ELISA data were calculated using a four-parameter logistic equation. Data were expressed as mean&#x000a0;&#x000b1;&#x000a0;SD and statistically analyzed using the GraphPad Prism software v5.0 (GraphPad software Inc., La Jolla, CA, USA). The normality of data distribution was determined using the Kolmogorov&#x02013;Smirnov test. The differences between groups were determined using the one-way ANOVA test followed by Tukey or Bonferroni post hoc test. Statistical significance was assumed when <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05.</p></sec></sec><sec id="Sec14"><title>Results</title><sec id="Sec15"><title><italic>B. canis</italic> characterization and growth curves</title><p id="Par16">The microbiological characterization of <italic>B. canis</italic> strain SCL used in the present study is shown in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. In culture, <italic>B. canis</italic> grew in convex, circular colonies of 1&#x02013;2-mm diameter (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A), and under optical microscopy, bacteria behaved as small Gram-negative coccobacillus (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>B). The biochemical profile was consistent with that described for other clinical isolates of <italic>B. canis</italic> [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]; in particular, bacteria were catalase and oxidase positive, and showed urease production before 30&#x000a0;s post-induction (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>C). Bacterial growth curves plotted as OD versus time and CFU/mL versus time are shown in Figures&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>D and E, respectively.<fig id="Fig1"><label>Figure&#x000a0;1</label><caption><p>
<bold><italic>Brucella canis</italic></bold>
<bold>microbiological characterization, LPS isolation and growth curves.</bold> Colonies growing on 5% horse blood agar (<bold>A</bold>), bacteria observed under optical microscopy (<bold>B</bold>), and biochemical profile analyzed under different conditions (<bold>C</bold>). Bacterial growth curves plotted as time versus optical density (OD) (<bold>D</bold>) and time versus colony-forming units/mL (CFU/mL) (<bold>E</bold>). Silver stained SDS-PAGE (<bold>F</bold>) and Comassie blue gels (<bold>G</bold>) of whole cellular membrane lysate of <italic>B. canis</italic> (lanes 1&#x02013;4) and its purified LPS (lanes 5&#x02013;8).</p></caption><graphic xlink:href="13567_2017_476_Fig1_HTML" id="MO1"/></fig>
</p></sec><sec id="Sec16"><title><italic>Brucella canis</italic> LPS is compatible with rough LPS</title><p id="Par17">When the whole cellular membrane lysates from <italic>B. canis</italic> were analyzed (lanes 1&#x02013;4), silver stained SDS-PAGE (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>F) revealed some upper bands that could be confused with the presence of O-polysaccharide; however, the detection of this bands in Coomassie blue stained gels (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>G) strongly suggest that they correspond to protein structures. When the LPS purified from <italic>B. canis</italic> was analyzed (lanes 5&#x02013;8), only bands compatibles with LPS from rough bacteria (core and lipid-A) were detected, and the upper bands were not present in both the silver stained SDS-PAGE gel and the Coomassie blue gel. In general terms, the use of the TRIzol based protocol resulted effective for obtaining a purified LPS from rough <italic>B. canis.</italic>
</p></sec><sec id="Sec17"><title>Highly pure human and canine dendritic cell cultures were obtained</title><p id="Par18">The DC differentiation was demonstrated by the combined staining with anti-CD1a, CD11c, and CD14 monoclonal antibodies analyzed by flow cytometry (Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A). Dendritic cells were identified by FSC and SSC parameters, and debris or doublets were excluded from the analyses. About 95% of the obtained human cell cultures were positive for the superficial markers CD1a and CD11c, while around 90% of the canine cells resulted positive for these two markers. In addition, canine and human DCs expressed very low and un-detected levels of the monocyte-macrophage marker CD14, respectively, thus indicating that highly purified populations of differentiated DCs were used for <italic>B. canis</italic> stimulation.<fig id="Fig2"><label>Figure&#x000a0;2</label><caption><p>
<bold>DC cultures purity and activation.</bold> DC differentiation from blood purified monocytes in the presence of GM-CSF and IL-4 was identified by flow cytometry according to forward scatter (FSC) and side scatter (SSC) parameters. Gated human and canine DCs were analyzed for expression of CD1a, CD11c, and CD14 and <italic>B. canis</italic>-stimulated labelled DCs (shaded histograms) were compared to FMO (fluorescence minus one) control (black solid line) (<bold>A</bold>). Activation and maturation levels of DCs after stimulation with <italic>B. canis</italic>: human and canine DCs were identified according to FSC and SSC parameters, and gated cells were analyzed for expression of CD86, CD83, and DLA II (shaded histograms) and compared to non-stimulated cells (black solid line) (<bold>B</bold>). Mean fluorescence intensity (MFI) for each surface marker shown in <bold>B</bold> (<bold>C</bold>). *<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05&#x000a0;and&#x000a0; **<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01.</p></caption><graphic xlink:href="13567_2017_476_Fig2_HTML" id="MO2"/></fig>
</p></sec><sec id="Sec18"><title>Stimulation with <italic>B. canis</italic> induces activation and maturation of canine and human dendritic cells</title><p id="Par19">Both human and canine DCs showed upregulation of maturation and activation surface markers upon stimulation with <italic>B. canis</italic>. When human or canine DCs were stimulated with whole <italic>B. canis</italic>, a high proportion of cells increased the expression levels of CD86 (98.6 and&#x000a0;&#x0003e;&#x000a0;90.9%, respectively) and human CD83 (77.8%) or canine MHC II (58.2%) (Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>B). A less intensive increment in all markers was detected when DCs were stimulated with <italic>B. canis</italic> purified LPS, without differences as compared to <italic>E. coli</italic> LPS (Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>C). Scanning electron microscopy analysis showed morphological changes compatible with signs of cell activation in stimulated human and canine DCs, including increased cell size and development of long cell projections (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig3"><label>Figure&#x000a0;3</label><caption><p>
<bold>Morphologic changes in DCs after stimulation with</bold>
<bold><italic>B. canis</italic></bold>
<bold>or its purified LPS.</bold> Scanning electron microscopy analysis of human or canine DCs stimulated for 24&#x000a0;h with live <italic>B. canis</italic> or it purified LPS. Human <italic>B. canis</italic>-stimulated DCs (<bold>A</bold>) developed numerous long projections and their cell size was at least five times greater than non-stimulated DCs (<bold>D</bold>). LPS-stimulated DCs (<bold>B</bold>, <bold>C</bold>) also increased cell size and developed projection in a less intense manner. Canine stimulated DCs (<bold>E</bold>&#x02013;<bold>G</bold>) also showed increased cell size and developed projections. Non-stimulated human (<bold>D</bold>) and canine (<bold>H</bold>) DCs were round shaped with short projections.</p></caption><graphic xlink:href="13567_2017_476_Fig3_HTML" id="MO3"/></fig>
</p></sec><sec id="Sec19"><title>The 18S rRNA translates a suitable housekeeping gene and allows quantification of cytokine expression by RT-qPCR in canine dendritic cells</title><p id="Par20">Due to insufficient background regarding the adequate choice of reference genes for quantification of cytokine expression in canine DCs, the expression levels of three potential housekeeping genes were measured for RT-qPCR normalization (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). Primer pairs were designed to identify the 18S rRNA, GADPH, and TBP expression in 28 canine samples (Additional file <xref rid="MOESM1" ref-type="media">1</xref>) and the NormFinder algorithm was used for identifying the optimal normalization gene among the three selected candidates, according to stability of expression [<xref ref-type="bibr" rid="CR27">27</xref>]. The algorithm analysis revealed that 18S rRNA was the most stably expressed housekeeping gene, with a stability value of 0.304. Therefore, 18S rRNA was used as reference gene for RT-qPCR analyses.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>
<bold>Housepeeking genes for quantification of cytokine mRNA expression using RT-qPCR in canine DCs</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Target</th><th align="left">Stability value</th><th align="left">Standard error</th></tr></thead><tbody><tr><td align="left">GAPDH</td><td char="." align="char">0.659</td><td char="." align="char">0.186</td></tr><tr><td align="left">TBP</td><td char="." align="char">1.475</td><td char="." align="char">0.210</td></tr><tr><td align="left">18S rRNA</td><td char="." align="char">0.304</td><td char="." align="char">0.350</td></tr></tbody></table><table-wrap-foot><p>
<italic>GAPDH</italic> glyceraldehyde 3-phosphate dehydrogenase, <italic>TBP</italic> TATA box binding protein, <italic>18S rRNA</italic> subunit 18S ribosomal RNA.</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec20"><title>Canine dendritic cells elicit a Th1/Th17-pattern of cytokine expression while human cells elicit a Th1-pattern of cytokines upon <italic>B. canis</italic> stimulation</title><p id="Par21">Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> depicts the expression of pro-inflammatory cytokines in DCs stimulated with whole <italic>B. canis</italic>. The data, plotted as mRNA fold-change for each cytokine, showed a dose-dependent increase in the mRNA expression levels for IL-5, IL-6, IL-10, IL-12p35, IL-13, IL-17, IFN-&#x003b3;, TNF-&#x003b1;, and TGF-&#x003b2;1 (Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>A). When canine DCs were exposed to <italic>B. canis</italic>, an increment in the mRNA expression for the Th1-associated cytokines (IL-12 and IFN-&#x003b3;) and the Th17-associated cytokines (IL-6 and IL-17) was detected as compared to non-stimulated DCs (Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>B). Conversely, only the Th1-associated cytokines (IL-1&#x003b2;, IL-12, and TNF-&#x003b1;) were over-expressed in infected human DCs as compared to non-stimulated cells (Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>C).<fig id="Fig4"><label>Figure&#x000a0;4</label><caption><p>
<bold>Different cytokine mRNA expression in whole</bold>
<bold><italic>B. canis</italic></bold>
<bold>-stimulated canine or human DCs.</bold> Quantification of the cytokines IL-1&#x003b2;, IL-12p35, IFN-&#x003b3;, and TNF-&#x003b1; (Th1-type), IL-4, IL-5, and IL-13 (Th2-type), IL-6, IL-17, and IL-23 (Th17-type), and IL-10 and TGF-&#x003b2;1 (T regulatory-type) is represented as mRNA fold-change in DCs stimulated with whole <italic>B. canis</italic>. Dose-dependent increase in the cytokine mRNA expression when canine DCs were stimulated at MOIs&#x000a0;=&#x000a0;2&#x000a0;&#x000d7;&#x000a0;10<sup>&#x02212;1</sup> to 2&#x000a0;&#x000d7;&#x000a0;10<sup>2</sup> (<bold>A</bold>). Cytokine mRNA expression in canine (<bold>B</bold>) and human DCs (<bold>C</bold>), when cells were stimulated with whole <italic>B. canis</italic> at a MOI&#x000a0;=&#x000a0;2&#x000a0;&#x000d7;&#x000a0;10<sup>2</sup>. The cytokine mRNA expression in non-stimulated DCs was considered as 1, as a reference for fold-change in expression (N.S.). *<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05, **<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01, and ***<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001.</p></caption><graphic xlink:href="13567_2017_476_Fig4_HTML" id="MO4"/></fig>
</p></sec><sec id="Sec21"><title><italic>B. canis</italic> LPS stimulation induced a Th1/Th17-pattern of cytokine expression in canine DCs and a Th1-pattern of cytokines in human DCs</title><p id="Par22">Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref> depicts the expression of pro-inflammatory cytokines in DCs stimulated with <italic>B. canis</italic> purified LPS (1&#x000a0;&#x000b5;g/mL). An increment in mRNA expression for the Th1-associated cytokines (IL-12, IFN-&#x003b3;, and TNF-&#x003b1;) and the Th17-associated cytokines (IL-6 and IL-17) was detected in canine DCs stimulated with <italic>B. canis</italic> LPS as compared to non-stimulated DCs, and these increased cytokine levels were similar than those detected in <italic>E. coli</italic> LPS-stimulated DCs (Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>A). Conversely, only the Th1-associated cytokine IL-12 was over-expressed in LPS <italic>B. canis</italic>-stimulated human DCs as compared to non-stimulated cells (Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>B). Lower doses of <italic>B. canis</italic> purified LPS were also used (10 and 100&#x000a0;ng/mL) with slight or no effects on canine DC activation.<fig id="Fig5"><label>Figure&#x000a0;5</label><caption><p>
<bold>Cytokine mRNA expression in</bold>
<bold><italic>B. canis</italic></bold>
<bold>LPS-stimulated DCs.</bold> Quantification of the cytokines IL-1&#x003b2;, IL-12p35, IFN-&#x003b3;, and TNF-&#x003b1; (Th1-type), IL-4, IL-5, and IL-13 (Th2-type), IL-6, IL-17, and IL-23 (Th17-type), and IL-10 and TGF-&#x003b2;1 (T regulatory-type) is represented as mRNA fold-change in canine (<bold>A</bold>) and human (<bold>B</bold>) DCs stimulated with 1&#x000a0;&#x000b5;g/mL of <italic>B. canis</italic> purified LPS. DCs stimulated with 1&#x000a0;&#x000b5;g/mL LPS of <italic>E. coli</italic> strain 0128:B12 were used as controls. The cytokine mRNA expression in non-stimulated DCs was considered as 1, as a reference for fold-change in expression (N.S.). *<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 and&#x000a0;**<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01.</p></caption><graphic xlink:href="13567_2017_476_Fig5_HTML" id="MO5"/></fig>
</p></sec><sec id="Sec22"><title>When stimulated with <italic>B. canis,</italic> canine and human dendritic cells elicit Th1/Th17 and Th1-pattern of cytokines, respectively</title><p id="Par23">The described changes in the cytokine mRNA levels were consistent with the changes in protein levels evaluated by ELISA (Figure&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). A significant increment in the secreted levels of Th1 or Th17-associated cytokines (IFN-&#x003b3; and IL-17) was confirmed in canine DCs stimulated with whole <italic>B. canis</italic>, while stimulation with <italic>B. canis</italic> or <italic>E. coli</italic> purified LPS induced increased secretion of IFN-&#x003b3;, as compared to non-stimulated DCs. An increment of IL-12 was detected in <italic>B. canis</italic>-stimulated human DCs and also TNF-&#x003b1; production was detected in <italic>B. canis</italic> and <italic>E. coli</italic> LPS-stimulated DCs.<fig id="Fig6"><label>Figure&#x000a0;6</label><caption><p>
<bold>Cytokine secretion in DCs stimulated with</bold>
<bold><italic>B. canis</italic></bold>, <bold><italic>B. canis</italic></bold>
<bold>LPS or</bold>
<bold><italic>E. coli</italic></bold>
<bold>LPS.</bold> Quantification of human IL-12 and TNF-&#x003b1; (Th1-type) (<bold>A</bold>) and canine IFN-&#x003b3; and IL-17 (Th1 and Th17-type) (<bold>B</bold>) is represented as pg/mL in DCs stimulated with live <italic>B. canis</italic> or LPS. Non-stimulated DCs were used as control (N.S.). *<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05, **<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.01, and ***<italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001.</p></caption><graphic xlink:href="13567_2017_476_Fig6_HTML" id="MO6"/></fig>
</p></sec></sec><sec id="Sec23"><title>Discussion</title><p id="Par24">Brucellosis, a disease that affects different animal species, is caused by bacteria of the genus <italic>Brucella</italic> and some of them have zoonotic potential such as <italic>B. melitensis</italic>, <italic>B. abortus</italic>, <italic>B. suis</italic>, and <italic>B. canis</italic> [<xref ref-type="bibr" rid="CR30">30</xref>]. Although these bacteria have the ability to infect humans, <italic>B. canis</italic>, less infective than the others, is associated with fewer symptomatic diseases and low number of reported cases [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. It has been demonstrated that a large number of <italic>B. canis</italic> interacts with canine placental tissues and immune cells from different hosts [<xref ref-type="bibr" rid="CR31">31</xref>&#x02013;<xref ref-type="bibr" rid="CR36">36</xref>]; however, there is no evidence of interaction between <italic>B. canis</italic> and human or canine DCs. Several studies have reported that <italic>B. canis</italic> has the ability to infect human and murine phagocytes, but failed to demonstrate intracellular proliferation [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]; however, when bacteria are inoculated at the exponential growth phase, they can proliferate in murine macrophages [<xref ref-type="bibr" rid="CR37">37</xref>].</p><p id="Par25">In this study, peripheral monocytes from healthy donors were purified and then differentiated into DCs to analyze the effects of whole <italic>B. canis</italic> or its purified LPS and to compare the production of pro-inflammatory cytokines between canine and human cells. The differentiation and activation of DCs was associated with the loss of the monocyte-macrophage marker CD14 and increase in CD1a, CD11c, CD83, DLAII, and CD86 expression, a pattern consistent with previous studies [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. In addition, similar levels of DC activation were reached when stimulated with either whole bacteria, demonstrating that <italic>B. canis</italic> induces canine and human DC activation to a similar extent (Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Morphological changes consistent with signs of cell activation were also detected by scanning electron microscopy analyses (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Thus, the differential DC response triggered shown between dogs and humans may be explained by qualitative rather than quantitative differences in the DC activation, and these differences may be caused by the differential immunogenicity demonstrated by <italic>B. canis</italic>. The present data indicate that <italic>B. canis</italic> induced an immune response biased towards both a Th1 and Th17 pattern of cytokine production in canine DCs; however, an immune response biased only towards a Th1 pattern of cytokine production was detected in human DCs (Figures&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>, <xref rid="Fig6" ref-type="fig">6</xref>). The same cytokine patterns were detected when canine or human DCs were stimulated with <italic>B. canis</italic> purified LPS, demonstrating that its LPS contributes at least in part to the immune response detected against <italic>B. canis</italic> (Figures&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>, <xref rid="Fig6" ref-type="fig">6</xref>).</p><p id="Par26">Dendritic cells are key components of the innate immune response and act as a bridge for the adaptive immune response [<xref ref-type="bibr" rid="CR40">40</xref>]. They are antigen-presenting cells that circulate through the bloodstream in immature states and are scattered in nearly all tissues. Immature DCs capture microbial antigens and then turn into mature cells with the ability to stimulate na&#x000ef;ve T-lymphocytes, determining their Th-polarization and activation pattern, what in turn may define the disease phenotype, in particular whether a mild or severe infection is established [<xref ref-type="bibr" rid="CR41">41</xref>]. The differential host-dependent pathogenic potential of <italic>B. canis</italic> observed between dogs and humans could be explained, at least in part, by the differences in the pattern of cytokine production in stimulated DCs detected in the present study.</p><p id="Par27">It has been reported that an effective immune response against <italic>Brucella</italic> spp. is associated with the Th1-pattern cytokine production by induced DCs and T lymphocytes [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. In fact, DCs are key target cells for <italic>Brucella</italic> spp., playing a central role in both the innate recognition and the establishment of a robust adaptive response. Different <italic>Brucella</italic> spp., however, invade these cells, impairing their capability to eliminate intracellular bacteria and the development of an adequate Th1 immune response [<xref ref-type="bibr" rid="CR43">43</xref>].</p><p id="Par28">Although in the present study it was detected an increment in the Th1 promoting cytokines IL-12 and IFN-&#x003b3; in <italic>B. canis</italic>-stimulated canine DCs, it was also detected a significant increment in the Th17 polarizing cytokines IL-6 and IL-17, which was an interesting finding due to the lack of previous reports demonstrating the production of IL-17 by canine DCs. In this context, <italic>B. canis</italic>-stimulated human DCs over-expressed exclusively Th1 polarizing cytokines IL-1&#x003b2;, IL-12, and TNF-&#x003b1; (Figures&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>, <xref rid="Fig6" ref-type="fig">6</xref>), suggesting that this pattern could lead to an effective Th1 immune response. Production of IL-12 and TNF-&#x003b1; by macrophages and DCs has been directly related with the control <italic>B. abortus</italic> infection [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>] and IL-1&#x003b2; promotes macrophage activation impairing replication of intracellular bacteria such as <italic>Mycobacterium tuberculosis</italic> by a process mediated by TNF-&#x003b1; secretion and TNFR1 cell surface expression [<xref ref-type="bibr" rid="CR46">46</xref>]. Interestingly, Th17-type cytokines have been widely described in phagocytes stimulated with different species of <italic>Brucella</italic> [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]; however, the interpretation of these type of immune response in canine DCs can be complicated, considering that on one hand Th17 is not a fully differentiated phenotype and remain some cell plasticity, which can lead to a protective or harmful immune response in different cases [<xref ref-type="bibr" rid="CR49">49</xref>]. On the other hand, although the Th17 subset in dogs has been described and associated with chronic inflammation [<xref ref-type="bibr" rid="CR50">50</xref>], there is not enough background in this field of canine immunology.</p><p id="Par29">Th17 lymphocytes are considered a potent pro-inflammatory and osteoclastogenic cell population, closely associated with autoimmune disorders [<xref ref-type="bibr" rid="CR48">48</xref>]. In addition, although the Th17-related immune response can be effective against extracellular bacterial or fungal infections, it is considered ineffective to control intracellular bacterial infections [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. The Th17 cell subset has been associated with the development of osteoarticular lesions in different hosts infected by <italic>Brucella</italic> spp. [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR53">53</xref>], although it has been also suggested that the combination Th1/Th17 response induced by oral vaccines would be suitable to control <italic>Brucella</italic> spp. infection [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. There is evidence indicating that only a Th1 response is protective against <italic>B. melitensis</italic> and the development of a Th17 combined immune response do not affect the course of infection [<xref ref-type="bibr" rid="CR55">55</xref>]. One possible explanation for these opposite effects is that the Th17 protective role refers to a local immune response in the gut, where Th17 lymphocytes usually play an important defensive role maintaining the mucosal homeostasis and integrity [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. In fact, there is evidence that an oral vaccine can lead to a protective Th1/Th17 response that protects mice from an oral administration of live <italic>Brucella</italic>, but the parenteral administration of the same antigen lead to a Th1 response, that protects mice from a systemic challenge [<xref ref-type="bibr" rid="CR54">54</xref>].</p><p id="Par30">
<italic>Mycobacterium tuberculosis</italic> is a widely studied intracellular bacterium that induces a protective Th1 response, with the parallel development of a detrimental Th17 response that contributes with the clinical symptoms and favours the formation of granulomas in affected organs [<xref ref-type="bibr" rid="CR57">57</xref>]. It is well known that IL-17 promotes granulopoiesis [<xref ref-type="bibr" rid="CR52">52</xref>], although some <italic>Brucella</italic> spp. are differently resistant to neutrophil response [<xref ref-type="bibr" rid="CR58">58</xref>]; furthermore, different <italic>Brucella</italic> spp., including <italic>B. canis</italic>, are able to resist killing by bovine neutrophils [<xref ref-type="bibr" rid="CR59">59</xref>]. Considering that the main consequences of <italic>B. canis</italic> infection are osteoarticular lesions such as diskospondylitis and the presence of granulomatous lesions in affected organs [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>], it is possible to assume that the presence of IL-6 and IL-17 could lead to a Th17-pattern of immune response, contributing to the brucellosis pathogenicity in infected dogs. In fact, increased serological levels of IL-17 are detected in human patients affected of acute brucellosis and these levels decrease after receiving antibiotic treatment, which indicates this cytokine is directly involved with the pathogenesis of human brucellosis [<xref ref-type="bibr" rid="CR62">62</xref>].</p><p id="Par31">In human Th lymphocytes, the Th17 cell plasticity can lead to different subsets, including IL-17/IL-10 secreting cells that in some cases can be protective for some bacterial infections; however, Th17 cells can also acquire the ability of IL-17/IFN-&#x003b3; production that promote chronicity in inflammatory disorders [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. When Th17 knockout mice were infected with <italic>B. melitensis</italic>, no effect was described after elimination of this cell subset, revealing that Th17 cells may not affect the course of the infection [<xref ref-type="bibr" rid="CR55">55</xref>]. In relation to this, although Th17 lymphocytes have been implicated with pathogenicity of rheumatoid arthritis, many IL-17 targeted therapies have failed to control the disease signs and symptoms [<xref ref-type="bibr" rid="CR64">64</xref>]. However, the use of antibodies that neutralize TNF-&#x003b1;, a cytokine that can bias Th17 cells towards pathogenic Th1/Th17 cells, can specifically decrease this cell subset, improving symptomatic lesions [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. This indicate that a variety of Th17 cells can be induced and differentially affect the immune response.</p><p id="Par32">The results of the present investigation strongly suggest that the differences in the cytokine patterns observed between canine and human DCs could have an impact in the development of the <italic>B. canis</italic> infection. Thus, a more effective Th1 immune response is displayed in human, while a Th1/Th17 immune response is displayed in dogs, impairing the elimination of the bacteria and favoring its pathogenicity. The involvement of the Th17-type immune response could also explain the long periods of asymptomatic relapses, because these cells are characterized by long periods of dormant phases, followed by short periods of cell activation. Taken together, these data contribute at least in part to elucidate the canine brucellosis immunopathology and to a better understanding of canine immunology through the description of IL-17 producing canine DCs.</p></sec><sec sec-type="supplementary-material"><title>Additional files</title><sec id="Sec24"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13567_2017_476_MOESM1_ESM.docx"><caption><p>
<bold>Additional file 1.</bold>
<bold>Canine primers.</bold> Canine forward and reverse primers for cytokine and endogenous control amplifications by RT-qPCR.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13567_2017_476_MOESM2_ESM.docx"><caption><p>
<bold>Additional file 2.</bold>
<bold>Human primers.</bold> Human forward and reverse primers for cytokine and endogenous control amplifications by RT-qPCR.</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p>Arturo Ferreira and Rolando Vernal contributed equally to this work</p></fn><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (10.1186/s13567-017-0476-8) contains supplementary material, which is available to authorized users.</p></fn></fn-group><ack><title>Competing interests</title><p>The authors declare that they have no competing interests.</p><sec id="FPar1"><title>Authors&#x02019; contributions</title><p id="Par33">MP did the scientific work with the support of AF and RV, designed and implemented the study, processed the biological samples, performed the cell cultures, carried out the ELISA experiments, performed the data analysis, and critically evaluated and supplemented the manuscript. CR and CB carried out the microbiology experiments. MP, FC and CA carried out the RT-qPCR experiments. MP, AF and RV prepared the figures and the manuscript for submission. All authors read and approved the final manuscript.</p></sec><sec id="FPar2"><title>Acknowledgements</title><p id="Par34">The authors thank Jocelyn Arias and Leonor Diaz (Microbiology Laboratory) for their generous support with bacterial cultures and LPS purification, Daniela del Pino for her support in blood sample procedures of canine donors, Roc&#x000ed;o Orellana (Scanning electron microscopy Laboratory), Barbara Pesce (FACS-Laboratory) and Milton Larrondo and Claudio P&#x000e9;rez from the Clinical Hospital of Universidad de Chile.</p></sec><sec id="FPar3"><title>Funding</title><p id="Par35">This work was financially supported by the Comisi&#x000f3;n Nacional de Investigaci&#x000f3;n Cient&#x000ed;fica y Tecnol&#x000f3;gica (CONICYT) from the Chilean Government, Grant FONDECYT 1140904. MP was a recipient of the fellowship CONICYT 21130626.</p></sec><sec id="FPar4"><title>Publisher&#x02019;s Note</title><p id="Par36">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollett</surname><given-names>RB</given-names></name></person-group><article-title>Canine brucellosis: outbreaks and compliance</article-title><source>Theriogenology</source><year>2006</year><volume>66</volume><fpage>575</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1016/j.theriogenology.2006.04.011</pub-id><?supplied-pmid 16716382?><pub-id pub-id-type="pmid">16716382</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanke</surname><given-names>MM</given-names></name></person-group><article-title>Canine brucellosis</article-title><source>Anim Reprod Sci</source><year>2004</year><volume>82&#x02013;83</volume><fpage>195</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1016/j.anireprosci.2004.05.005</pub-id><?supplied-pmid 15271453?><pub-id pub-id-type="pmid">15271453</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucero</surname><given-names>NE</given-names></name><name><surname>Corazza</surname><given-names>R</given-names></name><name><surname>Almuzara</surname><given-names>MN</given-names></name><name><surname>Reynes</surname><given-names>E</given-names></name><name><surname>Escobar</surname><given-names>GI</given-names></name><name><surname>Boeri</surname><given-names>E</given-names></name><name><surname>Ayala</surname><given-names>SM</given-names></name></person-group><article-title>Human <italic>Brucella canis</italic> outbreak linked to infection in dogs</article-title><source>Epidemiol Infect</source><year>2010</year><volume>138</volume><fpage>280</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1017/S0950268809990525</pub-id><?supplied-pmid 19653929?><pub-id pub-id-type="pmid">19653929</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keid</surname><given-names>LB</given-names></name><name><surname>Chiebao</surname><given-names>DP</given-names></name><name><surname>Batinga</surname><given-names>MCA</given-names></name><name><surname>Faita</surname><given-names>T</given-names></name><name><surname>Diniz</surname><given-names>JA</given-names></name><name><surname>Oliveira</surname><given-names>T</given-names></name><name><surname>Ferreira</surname><given-names>HL</given-names></name><name><surname>Soares</surname><given-names>RM</given-names></name></person-group><article-title><italic>Brucella canis</italic> infection in dogs from commercial breeding kennels in Brazil</article-title><source>Transbound Emerg Dis</source><year>2017</year><volume>64</volume><fpage>691</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1111/tbed.12632</pub-id><?supplied-pmid 28296215?><pub-id pub-id-type="pmid">28296215</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buzgan</surname><given-names>T</given-names></name><name><surname>Karahocagil</surname><given-names>MK</given-names></name><name><surname>Irmak</surname><given-names>H</given-names></name><name><surname>Baran</surname><given-names>AI</given-names></name><name><surname>Karsen</surname><given-names>H</given-names></name><name><surname>Evirgen</surname><given-names>O</given-names></name><name><surname>Akdeniz</surname><given-names>H</given-names></name></person-group><article-title>Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature</article-title><source>Int J Infect Dis</source><year>2010</year><volume>14</volume><fpage>e469</fpage><lpage>e478</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2009.06.031</pub-id><?supplied-pmid 19910232?><pub-id pub-id-type="pmid">19910232</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>EJ</given-names></name></person-group><article-title>An overview of human brucellosis</article-title><source>Clin Infect Dis</source><year>1995</year><volume>21</volume><fpage>283</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1093/clinids/21.2.283</pub-id><?supplied-pmid 8562733?><pub-id pub-id-type="pmid">8562733</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallach</surname><given-names>JC</given-names></name><name><surname>Giambartolomei</surname><given-names>GH</given-names></name><name><surname>Baldi</surname><given-names>PC</given-names></name><name><surname>Fossati</surname><given-names>CA</given-names></name></person-group><article-title>Human infection with M-strain of <italic>Brucella canis</italic></article-title><source>Emerg Infect Dis</source><year>2004</year><volume>10</volume><fpage>146</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.3201/eid1001.020622</pub-id><?supplied-pmid 15078613?><pub-id pub-id-type="pmid">15078613</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marzetti</surname><given-names>S</given-names></name><name><surname>Carranza</surname><given-names>C</given-names></name><name><surname>Roncallo</surname><given-names>M</given-names></name><name><surname>Escobar</surname><given-names>GI</given-names></name><name><surname>Lucero</surname><given-names>NE</given-names></name></person-group><article-title>Recent trends in human <italic>Brucella canis</italic> infection</article-title><source>Comp Immunol Microbiol Infect Dis</source><year>2013</year><volume>36</volume><fpage>55</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.cimid.2012.09.002</pub-id><?supplied-pmid 23040615?><pub-id pub-id-type="pmid">23040615</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angel</surname><given-names>MO</given-names></name><name><surname>Ristow</surname><given-names>P</given-names></name><name><surname>Ko</surname><given-names>AI</given-names></name><name><surname>Di-Lorenzo</surname><given-names>C</given-names></name></person-group><article-title>Serological trail of <italic>Brucella</italic> infection in an urban slum population in Brazil</article-title><source>J Infect Dev Ctries</source><year>2012</year><volume>6</volume><fpage>675</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.3855/jidc.2347</pub-id><?supplied-pmid 23000868?><pub-id pub-id-type="pmid">23000868</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucero</surname><given-names>NE</given-names></name><name><surname>Escobar</surname><given-names>GI</given-names></name><name><surname>Ayala</surname><given-names>SM</given-names></name><name><surname>Jacob</surname><given-names>N</given-names></name></person-group><article-title>Diagnosis of human brucellosis caused by <italic>Brucella canis</italic></article-title><source>J Med Microbiol</source><year>2005</year><volume>54</volume><fpage>457</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.45927-0</pub-id><?supplied-pmid 15824423?><pub-id pub-id-type="pmid">15824423</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucero</surname><given-names>NE</given-names></name><name><surname>Jacob</surname><given-names>NO</given-names></name><name><surname>Ayala</surname><given-names>SM</given-names></name><name><surname>Escobar</surname><given-names>GI</given-names></name><name><surname>Tuccillo</surname><given-names>P</given-names></name><name><surname>Jacques</surname><given-names>I</given-names></name></person-group><article-title>Unusual clinical presentation of brucellosis caused by <italic>Brucella canis</italic></article-title><source>J Med Microbiol</source><year>2005</year><volume>54</volume><fpage>505</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.45928-0</pub-id><?supplied-pmid 15824432?><pub-id pub-id-type="pmid">15824432</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucero</surname><given-names>NE</given-names></name><name><surname>Maldonado</surname><given-names>PI</given-names></name><name><surname>Kaufman</surname><given-names>S</given-names></name><name><surname>Escobar</surname><given-names>GI</given-names></name><name><surname>Boeri</surname><given-names>E</given-names></name><name><surname>Jacob</surname><given-names>NR</given-names></name></person-group><article-title><italic>Brucella canis</italic> causing infection in an HIV-infected patient</article-title><source>Vector Borne Zoonotic Dis</source><year>2010</year><volume>10</volume><fpage>527</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1089/vbz.2009.0034</pub-id><?supplied-pmid 19725766?><pub-id pub-id-type="pmid">19725766</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayan</surname><given-names>M</given-names></name><name><surname>Erdenlig</surname><given-names>S</given-names></name><name><surname>Stack</surname><given-names>J</given-names></name><name><surname>Kilic</surname><given-names>S</given-names></name><name><surname>Guducuoglu</surname><given-names>H</given-names></name><name><surname>Aksoy</surname><given-names>Y</given-names></name><name><surname>Baklan</surname><given-names>A</given-names></name><name><surname>Etiler</surname><given-names>N</given-names></name></person-group><article-title>A serological diagnostic survey for <italic>Brucella canis</italic> infection in Turkish patients with Brucellosis-like symptoms</article-title><source>Jpn J Infect Dis</source><year>2011</year><volume>64</volume><fpage>516</fpage><lpage>519</lpage><?supplied-pmid 22116333?><pub-id pub-id-type="pmid">22116333</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Archambaud</surname><given-names>C</given-names></name><name><surname>Salcedo</surname><given-names>SP</given-names></name><name><surname>Lelouard</surname><given-names>H</given-names></name><name><surname>Devilard</surname><given-names>E</given-names></name><name><surname>de Bovis</surname><given-names>B</given-names></name><name><surname>Van Rooijen</surname><given-names>N</given-names></name><name><surname>Gorvel</surname><given-names>JP</given-names></name><name><surname>Malissen</surname><given-names>B</given-names></name></person-group><article-title>Contrasting roles of macrophages and dendritic cells in controlling initial pulmonary <italic>Brucella</italic> infection</article-title><source>Eur J Immunol</source><year>2010</year><volume>40</volume><fpage>3458</fpage><lpage>3471</lpage><pub-id pub-id-type="doi">10.1002/eji.201040497</pub-id><?supplied-pmid 21108467?><pub-id pub-id-type="pmid">21108467</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salcedo</surname><given-names>SP</given-names></name><name><surname>Marchesini</surname><given-names>MI</given-names></name><name><surname>Lelouard</surname><given-names>H</given-names></name><name><surname>Fugier</surname><given-names>E</given-names></name><name><surname>Jolly</surname><given-names>G</given-names></name><name><surname>Balor</surname><given-names>S</given-names></name><name><surname>Muller</surname><given-names>A</given-names></name><name><surname>Lapaque</surname><given-names>N</given-names></name><name><surname>Demaria</surname><given-names>O</given-names></name><name><surname>Alexopoulou</surname><given-names>L</given-names></name><name><surname>Comerci</surname><given-names>DJ</given-names></name><name><surname>Ugalde</surname><given-names>RA</given-names></name><name><surname>Pierre</surname><given-names>P</given-names></name><name><surname>Gorvel</surname><given-names>JP</given-names></name></person-group><article-title><italic>Brucella</italic> control of dendritic cell maturation is dependent on the TIR-containing protein Btp1</article-title><source>PLoS Pathog</source><year>2008</year><volume>4</volume><fpage>e21</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.0040021</pub-id><?supplied-pmid 18266466?><pub-id pub-id-type="pmid">18266466</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billard</surname><given-names>E</given-names></name><name><surname>Cazevieille</surname><given-names>C</given-names></name><name><surname>Dornand</surname><given-names>J</given-names></name><name><surname>Gross</surname><given-names>A</given-names></name></person-group><article-title>High susceptibility of human dendritic cells to invasion by the intracellular pathogens <italic>Brucella suis</italic>, <italic>B. abortus</italic>, and <italic>B. melitensis</italic></article-title><source>Infect Immun</source><year>2005</year><volume>73</volume><fpage>8418</fpage><lpage>8424</lpage><pub-id pub-id-type="doi">10.1128/IAI.73.12.8418-8424.2005</pub-id><?supplied-pmid 16299342?><pub-id pub-id-type="pmid">16299342</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atluri</surname><given-names>VL</given-names></name><name><surname>Xavier</surname><given-names>MN</given-names></name><name><surname>de Jong</surname><given-names>MF</given-names></name><name><surname>den Hartigh</surname><given-names>AB</given-names></name><name><surname>Tsolis</surname><given-names>RE</given-names></name></person-group><article-title>Interactions of the human pathogenic <italic>Brucella</italic> species with their hosts</article-title><source>Annu Rev Microbiol</source><year>2011</year><volume>65</volume><fpage>523</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1146/annurev-micro-090110-102905</pub-id><?supplied-pmid 21939378?><pub-id pub-id-type="pmid">21939378</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>M</given-names></name><name><surname>Martire</surname><given-names>D</given-names></name><name><surname>Scotet</surname><given-names>E</given-names></name><name><surname>Bonneville</surname><given-names>M</given-names></name><name><surname>Sanchez</surname><given-names>F</given-names></name><name><surname>Lafont</surname><given-names>V</given-names></name></person-group><article-title>Full restoration of <italic>Brucella</italic>-infected dendritic cell functionality through V&#x003b3;9V&#x003b4;2 T helper type 1 crosstalk</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e43613</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0043613</pub-id><?supplied-pmid 22928003?><pub-id pub-id-type="pmid">22928003</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borie</surname><given-names>C</given-names></name><name><surname>Cepeda</surname><given-names>R</given-names></name><name><surname>Villarroel</surname><given-names>M</given-names></name><name><surname>De Los</surname><given-names>Reyes M</given-names></name></person-group><article-title>Description of reproductive characteristics of three <italic>Brucella canis</italic> seropositive dogs</article-title><source>Arch Med Vet</source><year>2002</year><volume>34</volume><fpage>111</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.4067/S0301-732X2002000100012</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alton</surname><given-names>GG</given-names></name><name><surname>Jones</surname><given-names>LM</given-names></name><name><surname>Pietz</surname><given-names>DE</given-names></name></person-group><article-title>Laboratory techniques in brucellosis</article-title><source>Monogr Ser World Health Organ.</source><year>1975</year><volume>55</volume><fpage>1</fpage><lpage>163</lpage></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>EC</given-names></name><name><surname>Hackett</surname><given-names>M</given-names></name></person-group><article-title>Rapid isolation method for lipopolysaccharide and lipid A from Gram-negative bacteria</article-title><source>Analyst</source><year>2000</year><volume>125</volume><fpage>651</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1039/b000368i</pub-id><?supplied-pmid 10892021?><pub-id pub-id-type="pmid">10892021</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>CM</given-names></name><name><surname>Frasch</surname><given-names>CE</given-names></name></person-group><article-title>A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels</article-title><source>Anal Biochem</source><year>1982</year><volume>119</volume><fpage>115</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(82)90673-X</pub-id><?supplied-pmid 6176137?><pub-id pub-id-type="pmid">6176137</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vernal</surname><given-names>R</given-names></name><name><surname>Le&#x000f3;n</surname><given-names>R</given-names></name><name><surname>Herrera</surname><given-names>D</given-names></name><name><surname>Garcia-Sanz</surname><given-names>JA</given-names></name><name><surname>Silva</surname><given-names>A</given-names></name><name><surname>Sanz</surname><given-names>M</given-names></name></person-group><article-title>Variability in the response of human dendritic cells stimulated with <italic>Porphyromonas gingivalis</italic> or <italic>Aggregatibacter actinomycetemcomitans</italic></article-title><source>J Periodontal Res</source><year>2008</year><volume>43</volume><fpage>689</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0765.2007.01073.x</pub-id><?supplied-pmid 19031495?><pub-id pub-id-type="pmid">19031495</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayers</surname><given-names>D</given-names></name><name><surname>Clements</surname><given-names>DN</given-names></name><name><surname>Salway</surname><given-names>F</given-names></name><name><surname>Day</surname><given-names>PJ</given-names></name></person-group><article-title>Expression stability of commonly used reference genes in canine articular connective tissues</article-title><source>BMC Vet Res</source><year>2007</year><volume>3</volume><fpage>7</fpage><pub-id pub-id-type="doi">10.1186/1746-6148-3-7</pub-id><?supplied-pmid 17484782?><pub-id pub-id-type="pmid">17484782</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chamizo</surname><given-names>C</given-names></name><name><surname>Rubio</surname><given-names>JM</given-names></name><name><surname>Moreno</surname><given-names>J</given-names></name><name><surname>Alvar</surname><given-names>J</given-names></name></person-group><article-title>Semi-quantitative analysis of multiple cytokines in canine peripheral blood mononuclear cells by a single tube RT-PCR</article-title><source>Vet Immunol Immunopathol</source><year>2001</year><volume>83</volume><fpage>191</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1016/S0165-2427(01)00385-3</pub-id><?supplied-pmid 11730929?><pub-id pub-id-type="pmid">11730929</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chimura</surname><given-names>N</given-names></name><name><surname>Shibata</surname><given-names>S</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Kondo</surname><given-names>N</given-names></name><name><surname>Mori</surname><given-names>T</given-names></name><name><surname>Hoshino</surname><given-names>Y</given-names></name><name><surname>Kamishina</surname><given-names>H</given-names></name><name><surname>Maeda</surname><given-names>S</given-names></name></person-group><article-title>Suitable reference genes for quantitative real-time RT-PCR in total RNA extracted from canine whole blood using the PAXgene&#x02122; system</article-title><source>J Vet Med Sci</source><year>2011</year><volume>73</volume><fpage>1101</fpage><lpage>1104</lpage><pub-id pub-id-type="doi">10.1292/jvms.11-0050</pub-id><?supplied-pmid 21502728?><pub-id pub-id-type="pmid">21502728</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>CL</given-names></name><name><surname>Jensen</surname><given-names>JL</given-names></name><name><surname>&#x000d8;rntoft</surname><given-names>TF</given-names></name></person-group><article-title>Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets</article-title><source>Cancer Res</source><year>2004</year><volume>64</volume><fpage>5245</fpage><lpage>5250</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-0496</pub-id><?supplied-pmid 15289330?><pub-id pub-id-type="pmid">15289330</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>AR</given-names></name><name><surname>de Azevedo</surname><given-names>SS</given-names></name><name><surname>Pinheiro</surname><given-names>ES</given-names></name><name><surname>Genovez</surname><given-names>ME</given-names></name><name><surname>de Azevedo</surname><given-names>AS</given-names></name><name><surname>de Sousa Am&#x000e9;rico Batista</surname><given-names>C</given-names></name><name><surname>Alves</surname><given-names>CJ</given-names></name></person-group><article-title><italic>Brucella canis</italic> infection in dogs attended in veterinary clinics from patos, Para&#x000ed;ba state, Brazil</article-title><source>Braz J Microbiol</source><year>2011</year><volume>42</volume><fpage>1405</fpage><lpage>1408</lpage><pub-id pub-id-type="doi">10.1590/S1517-83822011000400023</pub-id><?supplied-pmid 24031770?><pub-id pub-id-type="pmid">24031770</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores-Castro</surname><given-names>R</given-names></name><name><surname>Suarez</surname><given-names>F</given-names></name><name><surname>Ramirez-Pfeiffer</surname><given-names>C</given-names></name><name><surname>Carmichael</surname><given-names>LE</given-names></name></person-group><article-title>Canine brucellosis: bacteriological and serological investigation of naturally infected dogs in Mexico City</article-title><source>J Clin Microbiol</source><year>1977</year><volume>6</volume><fpage>591</fpage><lpage>597</lpage><?supplied-pmid 591631?><pub-id pub-id-type="pmid">591631</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haque</surname><given-names>N</given-names></name><name><surname>Bari</surname><given-names>MS</given-names></name><name><surname>Hossain</surname><given-names>MA</given-names></name><name><surname>Muhammad</surname><given-names>N</given-names></name><name><surname>Ahmed</surname><given-names>S</given-names></name><name><surname>Rahman</surname><given-names>A</given-names></name><name><surname>Hoque</surname><given-names>SM</given-names></name><name><surname>Islam</surname><given-names>A</given-names></name></person-group><article-title>An overview of Brucellosis</article-title><source>Mymensingh Med J</source><year>2011</year><volume>20</volume><fpage>742</fpage><lpage>747</lpage><?supplied-pmid 22081201?><pub-id pub-id-type="pmid">22081201</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delpino</surname><given-names>MV</given-names></name><name><surname>Fossati</surname><given-names>CA</given-names></name><name><surname>Baldi</surname><given-names>PC</given-names></name></person-group><article-title>Proinflammatory response of human osteoblastic cell lines and osteoblast-monocyte interaction upon infection with <italic>Brucella</italic> spp</article-title><source>Infect Immun</source><year>2009</year><volume>77</volume><fpage>984</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.1128/IAI.01259-08</pub-id><?supplied-pmid 19103778?><pub-id pub-id-type="pmid">19103778</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Detilleux</surname><given-names>PG</given-names></name><name><surname>Deyoe</surname><given-names>BL</given-names></name><name><surname>Cheville</surname><given-names>NF</given-names></name></person-group><article-title>Entry and intracellular localization of <italic>Brucella</italic> spp. in vero cells: fluorescence and electron microscopy</article-title><source>Vet Pathol</source><year>1990</year><volume>27</volume><fpage>317</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1177/030098589002700503</pub-id><?supplied-pmid 2122572?><pub-id pub-id-type="pmid">2122572</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eskra</surname><given-names>L</given-names></name><name><surname>Covert</surname><given-names>J</given-names></name><name><surname>Glasner</surname><given-names>J</given-names></name><name><surname>Splitter</surname><given-names>G</given-names></name></person-group><article-title>Differential expression of iron acquisition genes by <italic>Brucella melitensis</italic> and <italic>Brucella canis</italic> during macrophage infection</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e31747</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0031747</pub-id><?supplied-pmid 22403618?><pub-id pub-id-type="pmid">22403618</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Martin</surname><given-names>AI</given-names></name><name><surname>Vizcaino</surname><given-names>N</given-names></name><name><surname>Fernandez-Lago</surname><given-names>L</given-names></name></person-group><article-title>Cholesterol, ganglioside GM1 and class A scavenger receptor contribute to infection by <italic>Brucella ovis</italic> and <italic>Brucella canis</italic> in murine macrophages</article-title><source>Microbes Infect</source><year>2010</year><volume>12</volume><fpage>246</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2009.12.008</pub-id><?supplied-pmid 20083220?><pub-id pub-id-type="pmid">20083220</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rittig</surname><given-names>MG</given-names></name><name><surname>Kaufmann</surname><given-names>A</given-names></name><name><surname>Robins</surname><given-names>A</given-names></name><name><surname>Shaw</surname><given-names>B</given-names></name><name><surname>Sprenger</surname><given-names>H</given-names></name><name><surname>Gemsa</surname><given-names>D</given-names></name><name><surname>Foulongne</surname><given-names>V</given-names></name><name><surname>Rouot</surname><given-names>B</given-names></name><name><surname>Dornand</surname><given-names>J</given-names></name></person-group><article-title>Smooth and rough lipopolysaccharide phenotypes of <italic>Brucella</italic> induce different intracellular trafficking and cytokine/chemokine release in human monocytes</article-title><source>J Leukoc Biol</source><year>2003</year><volume>74</volume><fpage>1045</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.1189/jlb.0103015</pub-id><?supplied-pmid 12960272?><pub-id pub-id-type="pmid">12960272</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyuranecz</surname><given-names>M</given-names></name><name><surname>Szeredi</surname><given-names>L</given-names></name><name><surname>Ronai</surname><given-names>Z</given-names></name><name><surname>Denes</surname><given-names>B</given-names></name><name><surname>Dencso</surname><given-names>L</given-names></name><name><surname>Dan</surname><given-names>A</given-names></name><name><surname>Palmai</surname><given-names>N</given-names></name><name><surname>Hauser</surname><given-names>Z</given-names></name><name><surname>Lami</surname><given-names>E</given-names></name><name><surname>Makrai</surname><given-names>L</given-names></name><name><surname>Erdelyi</surname><given-names>K</given-names></name><name><surname>Janosi</surname><given-names>S</given-names></name></person-group><article-title>Detection of <italic>Brucella canis</italic>-induced reproductive diseases in a kennel</article-title><source>J Vet Diagn Invest</source><year>2011</year><volume>23</volume><fpage>143</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1177/104063871102300127</pub-id><?supplied-pmid 21217047?><pub-id pub-id-type="pmid">21217047</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chacon-Diaz</surname><given-names>C</given-names></name><name><surname>Altamirano-Silva</surname><given-names>P</given-names></name><name><surname>Gonzalez-Espinoza</surname><given-names>G</given-names></name><name><surname>Medina</surname><given-names>MC</given-names></name><name><surname>Alfaro-Alarcon</surname><given-names>A</given-names></name><name><surname>Bouza-Mora</surname><given-names>L</given-names></name><name><surname>Jimenez-Rojas</surname><given-names>C</given-names></name><name><surname>Wong</surname><given-names>M</given-names></name><name><surname>Barquero-Calvo</surname><given-names>E</given-names></name><name><surname>Rojas</surname><given-names>N</given-names></name><name><surname>Guzman-Verri</surname><given-names>C</given-names></name><name><surname>Moreno</surname><given-names>E</given-names></name><name><surname>Chaves-Olarte</surname><given-names>E</given-names></name></person-group><article-title><italic>Brucella canis</italic> is an intracellular pathogen that induces a lower proinflammatory response than smooth zoonotic counterparts</article-title><source>Infect Immun</source><year>2015</year><volume>83</volume><fpage>4861</fpage><lpage>4870</lpage><pub-id pub-id-type="doi">10.1128/IAI.00995-15</pub-id><?supplied-pmid 26438796?><pub-id pub-id-type="pmid">26438796</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000ed;az-Z&#x000fa;&#x000f1;iga</surname><given-names>J</given-names></name><name><surname>Y&#x000e1;&#x000f1;ez</surname><given-names>JP</given-names></name><name><surname>Alvarez</surname><given-names>C</given-names></name><name><surname>Melgar-Rodr&#x000ed;guez</surname><given-names>S</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>M</given-names></name><name><surname>Sanz</surname><given-names>M</given-names></name><name><surname>Vernal</surname><given-names>R</given-names></name></person-group><article-title>Serotype-dependent response of human dendritic cells stimulated with <italic>Aggregatibacter actinomycetemcomitans</italic></article-title><source>J Clin Periodontol</source><year>2014</year><volume>41</volume><fpage>242</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1111/jcpe.12205</pub-id><?supplied-pmid 24256118?><pub-id pub-id-type="pmid">24256118</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vernal</surname><given-names>R</given-names></name><name><surname>Le&#x000f3;n</surname><given-names>R</given-names></name><name><surname>Silva</surname><given-names>A</given-names></name><name><surname>van Winkelhoff</surname><given-names>AJ</given-names></name><name><surname>Garcia-Sanz</surname><given-names>JA</given-names></name><name><surname>Sanz</surname><given-names>M</given-names></name></person-group><article-title>Differential cytokine expression by human dendritic cells in response to different <italic>Porphyromonas gingivalis</italic> capsular serotypes</article-title><source>J Clin Periodontol</source><year>2009</year><volume>36</volume><fpage>823</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.1111/j.1600-051X.2009.01462.x</pub-id><?supplied-pmid 19682172?><pub-id pub-id-type="pmid">19682172</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banchereau</surname><given-names>J</given-names></name><name><surname>Briere</surname><given-names>F</given-names></name><name><surname>Caux</surname><given-names>C</given-names></name><name><surname>Davoust</surname><given-names>J</given-names></name><name><surname>Lebecque</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>YJ</given-names></name><name><surname>Pulendran</surname><given-names>B</given-names></name><name><surname>Palucka</surname><given-names>K</given-names></name></person-group><article-title>Immunobiology of dendritic cells</article-title><source>Annu Rev Immunol</source><year>2000</year><volume>18</volume><fpage>767</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.18.1.767</pub-id><?supplied-pmid 10837075?><pub-id pub-id-type="pmid">10837075</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smyth</surname><given-names>CM</given-names></name><name><surname>Logan</surname><given-names>G</given-names></name><name><surname>Boadle</surname><given-names>R</given-names></name><name><surname>Rowe</surname><given-names>PB</given-names></name><name><surname>Smythe</surname><given-names>JA</given-names></name><name><surname>Alexander</surname><given-names>IE</given-names></name></person-group><article-title>Differential subcellular localization of CD86 in human PBMC-derived macrophages and DCs, and ultrastructural characterization by immuno-electron microscopy</article-title><source>Int Immunol</source><year>2005</year><volume>17</volume><fpage>123</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxh193</pub-id><?supplied-pmid 15623548?><pub-id pub-id-type="pmid">15623548</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billard</surname><given-names>E</given-names></name><name><surname>Dornand</surname><given-names>J</given-names></name><name><surname>Gross</surname><given-names>A</given-names></name></person-group><article-title><italic>Brucella suis</italic> prevents human dendritic cell maturation and antigen presentation through regulation of tumor necrosis factor alpha secretion</article-title><source>Infect Immun</source><year>2007</year><volume>75</volume><fpage>4980</fpage><lpage>4989</lpage><pub-id pub-id-type="doi">10.1128/IAI.00637-07</pub-id><?supplied-pmid 17635859?><pub-id pub-id-type="pmid">17635859</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skendros</surname><given-names>P</given-names></name><name><surname>Boura</surname><given-names>P</given-names></name></person-group><article-title>Immunity to brucellosis</article-title><source>Rev Sci Tech</source><year>2013</year><volume>32</volume><fpage>137</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.20506/rst.32.1.2190</pub-id><?supplied-pmid 23837372?><pub-id pub-id-type="pmid">23837372</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliveira</surname><given-names>FS</given-names></name><name><surname>Carvalho</surname><given-names>NB</given-names></name><name><surname>Brandao</surname><given-names>AP</given-names></name><name><surname>Gomes</surname><given-names>MT</given-names></name><name><surname>de Almeida</surname><given-names>LA</given-names></name><name><surname>Oliveira</surname><given-names>SC</given-names></name></person-group><article-title>Interleukin-1 receptor-associated kinase 4 is essential for initial host control of <italic>Brucella abortus</italic> infection</article-title><source>Infect Immun</source><year>2011</year><volume>79</volume><fpage>4688</fpage><lpage>4695</lpage><pub-id pub-id-type="doi">10.1128/IAI.05289-11</pub-id><?supplied-pmid 21844234?><pub-id pub-id-type="pmid">21844234</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sathiyaseelan</surname><given-names>J</given-names></name><name><surname>Goenka</surname><given-names>R</given-names></name><name><surname>Parent</surname><given-names>M</given-names></name><name><surname>Benson</surname><given-names>RM</given-names></name><name><surname>Murphy</surname><given-names>EA</given-names></name><name><surname>Fernandes</surname><given-names>DM</given-names></name><name><surname>Foulkes</surname><given-names>AS</given-names></name><name><surname>Baldwin</surname><given-names>CL</given-names></name></person-group><article-title>Treatment of <italic>Brucella</italic>-susceptible mice with IL-12 increases primary and secondary immunity</article-title><source>Cell Immunol</source><year>2006</year><volume>243</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2006.10.003</pub-id><?supplied-pmid 17184756?><pub-id pub-id-type="pmid">17184756</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaraman</surname><given-names>P</given-names></name><name><surname>Sada-Ovalle</surname><given-names>I</given-names></name><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Anderson</surname><given-names>AC</given-names></name><name><surname>Kuchroo</surname><given-names>VK</given-names></name><name><surname>Remold</surname><given-names>HG</given-names></name><name><surname>Behar</surname><given-names>SM</given-names></name></person-group><article-title>IL-1&#x003b2; promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation</article-title><source>J Immunol</source><year>2013</year><volume>190</volume><fpage>4196</fpage><lpage>4204</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1202688</pub-id><?supplied-pmid 23487424?><pub-id pub-id-type="pmid">23487424</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clapp</surname><given-names>B</given-names></name><name><surname>Skyberg</surname><given-names>JA</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Thornburg</surname><given-names>T</given-names></name><name><surname>Walters</surname><given-names>N</given-names></name><name><surname>Pascual</surname><given-names>DW</given-names></name></person-group><article-title>Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses</article-title><source>Infect Immun</source><year>2011</year><volume>79</volume><fpage>4165</fpage><lpage>4174</lpage><pub-id pub-id-type="doi">10.1128/IAI.05080-11</pub-id><?supplied-pmid 21768283?><pub-id pub-id-type="pmid">21768283</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giambartolomei</surname><given-names>GH</given-names></name><name><surname>Scian</surname><given-names>R</given-names></name><name><surname>Acosta-Rodriguez</surname><given-names>E</given-names></name><name><surname>Fossati</surname><given-names>CA</given-names></name><name><surname>Delpino</surname><given-names>MV</given-names></name></person-group><article-title><italic>Brucella abortus</italic>-infected macrophages modulate T lymphocytes to promote osteoclastogenesis via IL-17</article-title><source>Am J Pathol</source><year>2012</year><volume>181</volume><fpage>887</fpage><lpage>896</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2012.05.029</pub-id><?supplied-pmid 22901753?><pub-id pub-id-type="pmid">22901753</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basu</surname><given-names>R</given-names></name><name><surname>Hatton</surname><given-names>RD</given-names></name><name><surname>Weaver</surname><given-names>CT</given-names></name></person-group><article-title>The Th17 family: flexibility follows function</article-title><source>Immunol Rev</source><year>2013</year><volume>252</volume><fpage>89</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1111/imr.12035</pub-id><?supplied-pmid 23405897?><pub-id pub-id-type="pmid">23405897</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kol</surname><given-names>A</given-names></name><name><surname>Walker</surname><given-names>NJ</given-names></name><name><surname>Nordstrom</surname><given-names>M</given-names></name><name><surname>Borjesson</surname><given-names>DL</given-names></name></person-group><article-title>Th17 pathway as a target for multipotent stromal cell therapy in dogs: implications for translational research</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><fpage>e0148568</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0148568</pub-id><?supplied-pmid 26872054?><pub-id pub-id-type="pmid">26872054</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Audic</surname><given-names>S</given-names></name><name><surname>Lescot</surname><given-names>M</given-names></name><name><surname>Claverie</surname><given-names>JM</given-names></name><name><surname>Scholz</surname><given-names>HC</given-names></name></person-group><article-title><italic>Brucella microti</italic>: the genome sequence of an emerging pathogen</article-title><source>BMC Genomics</source><year>2009</year><volume>10</volume><fpage>352</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-10-352</pub-id><?supplied-pmid 19653890?><pub-id pub-id-type="pmid">19653890</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muranski</surname><given-names>P</given-names></name><name><surname>Restifo</surname><given-names>NP</given-names></name></person-group><article-title>Essentials of Th17 cell commitment and plasticity</article-title><source>Blood</source><year>2013</year><volume>121</volume><fpage>2402</fpage><lpage>2414</lpage><pub-id pub-id-type="doi">10.1182/blood-2012-09-378653</pub-id><?supplied-pmid 23325835?><pub-id pub-id-type="pmid">23325835</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giambartolomei</surname><given-names>GH</given-names></name><name><surname>Arriola Benitez</surname><given-names>PC</given-names></name><name><surname>Delpino</surname><given-names>MV</given-names></name></person-group><article-title><italic>Brucella</italic> and osteoarticular cell activation: partners in crime</article-title><source>Front Microbiol</source><year>2017</year><volume>8</volume><fpage>256</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.00256</pub-id><?supplied-pmid 28265268?><pub-id pub-id-type="pmid">28265268</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasquevich</surname><given-names>KA</given-names></name><name><surname>Ibanez</surname><given-names>AE</given-names></name><name><surname>Coria</surname><given-names>LM</given-names></name><name><surname>Garcia Samartino</surname><given-names>C</given-names></name><name><surname>Estein</surname><given-names>SM</given-names></name><name><surname>Zwerdling</surname><given-names>A</given-names></name><name><surname>Barrionuevo</surname><given-names>P</given-names></name><name><surname>Oliveira</surname><given-names>FS</given-names></name><name><surname>Seither</surname><given-names>C</given-names></name><name><surname>Warzecha</surname><given-names>H</given-names></name><name><surname>Oliveira</surname><given-names>SC</given-names></name><name><surname>Giambartolomei</surname><given-names>GH</given-names></name><name><surname>Cassataro</surname><given-names>J</given-names></name></person-group><article-title>An oral vaccine based on U-Omp19 induces protection against <italic>B. abortus</italic> mucosal challenge by inducing an adaptive IL-17 immune response in mice</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e16203</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0016203</pub-id><?supplied-pmid 21264260?><pub-id pub-id-type="pmid">21264260</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitry</surname><given-names>MA</given-names></name><name><surname>De Trez</surname><given-names>C</given-names></name><name><surname>Goriely</surname><given-names>S</given-names></name><name><surname>Dumoutier</surname><given-names>L</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Ryffel</surname><given-names>B</given-names></name><name><surname>Carlier</surname><given-names>Y</given-names></name><name><surname>Letesson</surname><given-names>JJ</given-names></name><name><surname>Muraille</surname><given-names>E</given-names></name></person-group><article-title>Crucial role of IFN-&#x003b3;-producing CD4<sup>+</sup> Th1 cells but dispensable function of CD8<sup>+</sup> T cell, B cell, Th2, and Th17 responses in the control of <italic>Brucella melitensis</italic> infection in mice</article-title><source>Infect Immun</source><year>2012</year><volume>80</volume><fpage>4271</fpage><lpage>4280</lpage><pub-id pub-id-type="doi">10.1128/IAI.00761-12</pub-id><?supplied-pmid 23006848?><pub-id pub-id-type="pmid">23006848</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bystrom</surname><given-names>J</given-names></name><name><surname>Taher</surname><given-names>TE</given-names></name><name><surname>Muhyaddin</surname><given-names>MS</given-names></name><name><surname>Clanchy</surname><given-names>FI</given-names></name><name><surname>Mangat</surname><given-names>P</given-names></name><name><surname>Jawad</surname><given-names>AS</given-names></name><name><surname>Williams</surname><given-names>RO</given-names></name><name><surname>Mageed</surname><given-names>RA</given-names></name></person-group><article-title>Harnessing the therapeutic potential of Th17 cells</article-title><source>Mediators Inflamm</source><year>2015</year><volume>2015</volume><fpage>205156</fpage><pub-id pub-id-type="doi">10.1155/2015/205156</pub-id><?supplied-pmid 26101460?><pub-id pub-id-type="pmid">26101460</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyadova</surname><given-names>IV</given-names></name><name><surname>Panteleev</surname><given-names>AV</given-names></name></person-group><article-title>Th1 and Th17 cells in tuberculosis: protection, pathology, and biomarkers</article-title><source>Mediators Inflamm</source><year>2015</year><volume>2015</volume><fpage>854507</fpage><pub-id pub-id-type="doi">10.1155/2015/854507</pub-id><?supplied-pmid 26640327?><pub-id pub-id-type="pmid">26640327</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>EJ</given-names></name><name><surname>Borchert</surname><given-names>M</given-names></name><name><surname>Kretzer</surname><given-names>FL</given-names></name><name><surname>Musher</surname><given-names>DM</given-names></name></person-group><article-title>Phagocytosis and killing of <italic>Brucella</italic> by human polymorphonuclear leukocytes</article-title><source>J Infect Dis</source><year>1985</year><volume>151</volume><fpage>682</fpage><lpage>690</lpage><pub-id pub-id-type="doi">10.1093/infdis/151.4.682</pub-id><?supplied-pmid 3919118?><pub-id pub-id-type="pmid">3919118</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keleher</surname><given-names>LL</given-names></name><name><surname>Skyberg</surname><given-names>JA</given-names></name></person-group><article-title>Activation of bovine neutrophils by <italic>Brucella</italic> spp</article-title><source>Vet Immunol Immunopathol</source><year>2016</year><volume>177</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.vetimm.2016.05.011</pub-id><?supplied-pmid 27436438?><pub-id pub-id-type="pmid">27436438</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>GI</given-names></name><name><surname>Binnington</surname><given-names>AG</given-names></name></person-group><article-title>Discospondylitis and orchitis associated with high <italic>Brucella titre</italic> in a dog</article-title><source>Can Vet J</source><year>1983</year><volume>24</volume><fpage>249</fpage><lpage>252</lpage><?supplied-pmid 17422294?><pub-id pub-id-type="pmid">17422294</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerwin</surname><given-names>SC</given-names></name><name><surname>Lewis</surname><given-names>DD</given-names></name><name><surname>Hribernik</surname><given-names>TN</given-names></name><name><surname>Partington</surname><given-names>B</given-names></name><name><surname>Hosgood</surname><given-names>G</given-names></name><name><surname>Eilts</surname><given-names>BE</given-names></name></person-group><article-title>Diskospondylitis associated with <italic>Brucella canis</italic> infection in dogs: 14 cases (1980&#x02013;1991)</article-title><source>J Am Vet Med Assoc</source><year>1992</year><volume>201</volume><fpage>1253</fpage><lpage>1257</lpage><?supplied-pmid 1429171?><pub-id pub-id-type="pmid">1429171</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sofian</surname><given-names>M</given-names></name><name><surname>Ramezani</surname><given-names>A</given-names></name><name><surname>Mousavi</surname><given-names>A</given-names></name><name><surname>Banifazl</surname><given-names>M</given-names></name><name><surname>Cherei</surname><given-names>S</given-names></name><name><surname>Cherei</surname><given-names>A</given-names></name><name><surname>Aghakhani</surname><given-names>A</given-names></name></person-group><article-title>Interleukin-17 and TGF-&#x003b2; levels in patients with acute brucellosis before and after treatment</article-title><source>Turk J Med Sci</source><year>2016</year><volume>46</volume><fpage>1348</fpage><lpage>1352</lpage><pub-id pub-id-type="doi">10.3906/sag-1506-59</pub-id><?supplied-pmid 27966296?><pub-id pub-id-type="pmid">27966296</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Annunziato</surname><given-names>F</given-names></name><name><surname>Cosmi</surname><given-names>L</given-names></name><name><surname>Liotta</surname><given-names>F</given-names></name><name><surname>Maggi</surname><given-names>E</given-names></name><name><surname>Romagnani</surname><given-names>S</given-names></name></person-group><article-title>Human Th1 dichotomy: origin, phenotype and biologic activities</article-title><source>Immunology</source><year>2014</year><?supplied-pmid 25284714?><pub-id pub-id-type="pmid">25284714</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alunno</surname><given-names>A</given-names></name><name><surname>Manetti</surname><given-names>M</given-names></name><name><surname>Caterbi</surname><given-names>S</given-names></name><name><surname>Ibba-Manneschi</surname><given-names>L</given-names></name><name><surname>Bistoni</surname><given-names>O</given-names></name><name><surname>Bartoloni</surname><given-names>E</given-names></name><name><surname>Valentini</surname><given-names>V</given-names></name><name><surname>Terenzi</surname><given-names>R</given-names></name><name><surname>Gerli</surname><given-names>R</given-names></name></person-group><article-title>Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory Th17 cells and therapeutic implications</article-title><source>Mediators Inflamm</source><year>2015</year><volume>2015</volume><fpage>751793</fpage><?supplied-pmid 25918479?><pub-id pub-id-type="pmid">25918479</pub-id></element-citation></ref></ref-list></back></article>